import { useState, useEffect, useRef, useCallback } from "react";
import { Link } from "react-router-dom";
import { ArrowRight, Calendar, Clock, ChevronDown, ChevronUp } from "lucide-react";
import Header from "@/components/Header";
import SEOHead from "@/components/SEOHead";
import StickyCTA from "@/components/StickyCTA";
import BottomVideo from "@/components/BottomVideo";
import johnHeadshot from "@/assets/john-headshot.jpg";
import nicoleHeadshot from "@/assets/nicole-headshot.jpeg";
import defaultHeroImage from "@/assets/insights-hero-default.jpg";
import articleFemtechVendor from "@/assets/article-femtech-vendor.jpg";
import articleMaternalHealth from "@/assets/article-maternal-health.jpg";
import articleMisdiagnosis from "@/assets/article-misdiagnosis.jpg";
import articleEpicStork from "@/assets/article-epic-stork.jpg";
import articleClinicalReadiness from "@/assets/article-clinical-readiness.jpg";
import articleFemtechPilots from "@/assets/article-femtech-pilots.jpg";
import articlePhysicianAdoption from "@/assets/article-physician-adoption.jpg";
import articleReimbursement from "@/assets/article-reimbursement.jpg";
import articleHealthSystemSales from "@/assets/article-health-system-sales.jpg";
import articleRoiWomensHealth from "@/assets/article-roi-womens-health.jpg";
import articlePcosDiagnosis from "@/assets/article-pcos-diagnosis.jpg";

// ─── ARTICLE DATA ─────────────────────────────────────────────
// To add a new article, simply add an object to this array.
// The most recent article should be first.
export interface Article {
  slug: string;
  title: string;
  excerpt: string;
  category: string;
  date: string;
  readTime: string;
  image?: string;
  author?: { name: string; title: string; bio: string; headshot: string };
  content: string;
}

const defaultAuthor = {
  name: "John Faulkner",
  title: "Founder & CEO, The Faulkner Group",
  bio: "John brings over 15 years of healthcare IT architecture and clinical strategy experience. He advises femtech founders and health systems on bridging the gap between technology and clinical adoption.",
  headshot: johnHeadshot,
};

const articles: Article[] = [
  {
    slug: "pcos-diagnosis-delay-health-systems",
    title: "PCOS in 2026: Why It Takes 7 Years to Diagnose and What Health Systems Can Do About It",
    excerpt:
      "At least 1 in 8 women has PCOS. Most of them spent years being told something else was wrong. A multi-year diagnostic delay is not a clinical mystery. It is a system failure with a documented root cause and a clear set of solutions.",
    category: "Women's Health",
    date: "March 10, 2026",
    readTime: "20 min read",
    image: articlePcosDiagnosis,
    content: `
      <p>At least 1 in 8 women has PCOS.</p>
      <p>Most of them spent years being told something else was wrong.</p>
      <p>Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting between 6% and 20% of women globally depending on diagnostic criteria. In the United States alone, it generates $8 billion in annual healthcare costs. It is the leading cause of female infertility. It is directly associated with type 2 diabetes, cardiovascular disease, endometrial cancer, and metabolic syndrome.</p>
      <p>And the average time from symptom onset to correct diagnosis is still 2 to 7 years.</p>
      <p>In a condition this prevalent, this costly, and this consequential, a multi-year diagnostic delay is not a clinical mystery. It is a system failure with a documented root cause and a clear set of solutions. Health systems that understand both will be the ones that change these outcomes.</p>

      <h2>Why PCOS Takes So Long to Diagnose</h2>
      <p>PCOS is not difficult to diagnose once a clinician considers it. The Rotterdam Criteria, the most widely used diagnostic framework, requires only two of the following three findings: irregular or absent ovulation, clinical or biochemical signs of elevated androgens, and polycystic ovarian morphology on ultrasound. These are not rare or hard-to-obtain findings.</p>
      <p>The delay is not diagnostic. It is structural.</p>
      <p>PCOS is dramatically underfunded as a research priority. Average annual research funding for PCOS from 2016 to 2022 was approximately $32 million. Rheumatoid arthritis, which affects a comparable number of patients, received $262 million over the same period. Tuberculosis received $66 million. The research gap produces a clinical knowledge gap. Clinicians who were not trained to recognize PCOS do not diagnose it.</p>
      <p>PCOS symptoms are routinely attributed to other conditions. Irregular periods get attributed to stress. Acne and hair growth are addressed as cosmetic concerns. Weight gain is addressed with lifestyle counseling. Anxiety and depression, which are significantly more prevalent in women with PCOS, are treated in isolation without investigating the underlying hormonal driver. Women with PCOS average multiple specialist referrals before anyone connects the pattern.</p>
      <p>The diagnostic criteria themselves create confusion. PCOS presents differently across phenotypes, body types, and racial backgrounds. South Asian women are 2.5 times more likely to be diagnosed with PCOS than white women, and African-Caribbean women are 1.8 times more likely. Yet the clinical training and symptom awareness that exists disproportionately reflects the white, higher-weight phenotype. Women who do not match that presentation are more likely to be missed.</p>
      <p>Access to care amplifies every gap. Women relying on Medicaid or charity care are 90% more likely to receive a missed PCOS diagnosis compared to women with private insurance. Rural access, cultural barriers, and socioeconomic inequality compound the diagnostic delay at every intersection.</p>

      <h2>What the Delay Actually Costs</h2>
      <p>PCOS-associated healthcare costs in the United States reached $8 billion in 2020. The majority of that cost is not concentrated in diagnosis or reproductive care. It is concentrated in the long-term management of metabolic complications that develop when PCOS goes unmanaged: type 2 diabetes, stroke, cardiovascular disease, and pregnancy complications including gestational diabetes and preeclampsia.</p>
      <p>These are not inevitable outcomes of PCOS. They are the outcomes of PCOS diagnosed too late to intervene effectively.</p>
      <p>A woman diagnosed with PCOS at 23 and placed on an appropriate management plan, including lifestyle support, hormonal regulation, and metabolic monitoring, has a materially different long-term health trajectory than a woman diagnosed at 30 after years of accumulating insulin resistance. The clinical literature is consistent on this point. Earlier diagnosis produces better outcomes across every major comorbidity associated with the condition.</p>
      <p>The U.S. PCOS treatment market is projected to reach $7.5 billion by 2032, growing at a 7.2% CAGR. That growth reflects rising diagnosis rates, increasing adoption of holistic and personalized care models, and growing recognition of PCOS as a lifelong metabolic condition rather than a reproductive one. Health systems that build strong PCOS care pathways now are positioning themselves for the fastest-growing segment of women's health clinical demand.</p>

      <h2>What a Strong PCOS Care Pathway Looks Like</h2>
      <p>Health systems committed to closing the PCOS diagnostic gap need to address three layers: clinical recognition, workflow infrastructure, and ongoing management.</p>

      <h2>Clinical Recognition</h2>
      <p>Every primary care provider, internal medicine physician, and OB/GYN who sees women of reproductive age needs foundational PCOS training that goes beyond the reproductive phenotype. This means training clinicians to recognize the metabolic presentation, the dermatologic presentation, and the psychological presentation of PCOS, not just the classic irregular cycle plus polycystic ovaries picture.</p>
      <p>It also means training clinicians to ask. Symptom-driven diagnostic workflows that include standardized PCOS screening questions during well-woman visits, annual physicals, and new patient intake for women aged 15 to 44 dramatically increase detection rates without adding significant clinical burden.</p>

      <h2>Workflow Infrastructure</h2>
      <p>PCOS detection does not require new technology. It requires existing technology configured correctly. In Epic, this means building PCOS screening prompts into well-woman visit templates, embedding Rotterdam Criteria documentation into OB/GYN SmartForms, and configuring Order Sets that bundle the appropriate hormonal and metabolic labs so that a PCOS workup can be initiated in a single click rather than requiring individual orders.</p>
      <p>It means building a referral pathway that connects the diagnosing provider, whether primary care or OB/GYN, to endocrinology, nutrition, and behavioral health in a coordinated way rather than leaving the patient to navigate specialty care independently.</p>
      <p>And it means configuring Epic Ambulatory workflows that track PCOS patients longitudinally, flagging overdue metabolic labs, missed follow-ups, and pregnancy planning conversations at the appropriate intervals.</p>

      <h2>Ongoing Management</h2>
      <p>PCOS is not a condition that resolves after a diagnosis and a prescription. It requires longitudinal management across the reproductive, metabolic, and psychological dimensions of the condition throughout a woman's lifespan. Health systems that build PCOS care programs, combining OB/GYN, endocrinology, nutrition, mental health, and patient education resources, produce meaningfully better outcomes and meaningfully lower long-term utilization than systems managing PCOS as a series of disconnected episodic encounters.</p>
      <p>Femtech solutions designed specifically for PCOS management, including symptom tracking, cycle monitoring, nutrition guidance, and provider communication tools, are advancing rapidly. Deploying them effectively requires a clinically ready health system environment, clear integration into the EHR, and clinical champions who understand the condition well enough to trust the data the tools generate.</p>

      <h2>The Equity Dimension Health Systems Cannot Ignore</h2>
      <p>PCOS disproportionately affects women of color, women in low-income communities, and women in rural areas with limited access to specialist care. The diagnostic delay is not evenly distributed. Women with Medicaid or charity insurance are nearly twice as likely to receive a missed diagnosis as women with private coverage. Women from South Asian and African-Caribbean backgrounds present with higher PCOS prevalence and face greater barriers to culturally competent care.</p>
      <p>A PCOS care strategy that does not explicitly address these disparities will not close the diagnostic gap. It will optimize care for the patients who were already getting it and leave the patients with the highest unmet need exactly where they were.</p>
      <p>Health systems that track PCOS diagnosis rates, time to diagnosis, and management outcomes by race, ethnicity, insurance status, and geography are the ones building the data infrastructure to identify and close those gaps. It is the same discipline that drives maternal health equity improvement. And it is the same discipline that turns population health strategy from a slide deck into a measurable outcome.</p>

      <h2>What Health Systems Must Do Now</h2>
      <ul>
        <li>Add structured PCOS screening to well-woman visit templates in Epic Ambulatory for all women aged 15 to 44</li>
        <li>Train primary care providers to recognize all three PCOS phenotypes, not just the classic reproductive presentation</li>
        <li>Build a coordinated PCOS referral pathway connecting OB/GYN, endocrinology, nutrition, and behavioral health in a single, navigable care model</li>
        <li>Audit current PCOS diagnosis rates by demographic and compare against expected population prevalence to identify where patients are being missed</li>
        <li>Evaluate femtech solutions designed for PCOS management through a formal clinical readiness process before deployment</li>
        <li>Track time to diagnosis and metabolic complication rates for PCOS patients as standing quality metrics reported at the clinical leadership level</li>
      </ul>

      <h2>How The Faulkner Group Helps</h2>
      <p>The Faulkner Group works with health systems to build the clinical readiness and workflow infrastructure that PCOS care demands. From Epic Ambulatory optimization to femtech vendor evaluation and clinical readiness assessment, we help health systems move from awareness of the problem to operational solutions that change outcomes.</p>
      <p>If your system is ready to build a PCOS care pathway that actually works, start with a Clinical Clarity Session.</p>
      <p style="margin-top: 2rem; display: flex; gap: 1rem; flex-wrap: wrap;">
        <a href="/clinical-clarity-session" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Book Your Clinical Clarity Session</a>
        <a href="/clinical-readiness-assessment" style="display: inline-block; border: 1px solid #C9A84C; color: #C9A84C; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Explore the Clinical Readiness Assessment</a>
      </p>
    `,
  },
  {
    slug: "roi-of-womens-health-business-case",
    title: "The ROI of Women's Health: How Health Systems Build the Business Case",
    excerpt:
      "Women drive 80% of all household healthcare decisions. And health systems are still treating their care as a cost center. That disconnect is not just a health equity problem. It is a financial miscalculation of historic proportions.",
    category: "Health System Strategy",
    date: "February 18, 2026",
    readTime: "18 min read",
    image: articleRoiWomensHealth,
    content: `
      <p>Women drive 80% of all household healthcare decisions.</p>
      <p>And health systems are still treating their care as a cost center.</p>
      <p>That disconnect is not just a health equity problem. It is a financial miscalculation of historic proportions. The data from BCG, the World Economic Forum, McKinsey, and WHAM all arrived at the same conclusion in 2026: women's health is not a niche investment. It is the single most undercapitalized opportunity in the entire healthcare economy.</p>
      <p>For health system CFOs, CMOs, and strategy leaders, the question is no longer whether women's health is worth investing in. The question is how long you can afford not to.</p>

      <h2>The Numbers Your CFO Needs to See</h2>
      <p>The WEF and BCG published the Women's Health Investment Outlook in January 2026, analyzing capital flows across the global women's health sector. The headline finding: women represent nearly 50% of the world's population but receive just 6% of private healthcare investment. Less than 1% of that goes to companies focused exclusively on women's health.</p>
      <p>The market opportunity that gap represents is not abstract. BCG calculated that addressing diagnosis and treatment gaps in just four conditions, including menopause, osteoporosis, cardiovascular disease, and Alzheimer's, could unlock more than $100 billion in market value by 2030. Forbes puts the addressable gap in the United States at $360 billion.</p>
      <p>WHAM's business case analysis found that $350 million invested in women's focused research yielded $14 billion in economic returns, a 40-to-one return on investment. Doubling investment in women's cardiovascular research alone could save nearly $2 billion in direct healthcare costs. Closing the 25% gap in women's health outcomes could contribute at least $1 trillion to global GDP annually.</p>
      <p>These are not projections from advocacy organizations. They are financial analyses from BCG, McKinsey, and the World Economic Forum.</p>

      <h2>Why Health Systems Leave This Money on the Table</h2>
      <p>The answer comes down to how women's health has been categorized internally. Most health system financial models treat OB/GYN, maternal care, and women's health services as high-volume, low-margin service lines. The reimbursement structures for obstetric care and gynecologic procedures have historically undervalued the work. And the downstream financial impact of poor women's health outcomes has rarely been attributed back to the service line that could have prevented them.</p>
      <p>That attribution gap is where the ROI conversation gets lost.</p>
      <p>A woman with unmanaged PCOS who develops type 2 diabetes and cardiovascular disease over the next decade costs the health system significantly more in chronic disease management than she would have cost to diagnose and treat appropriately at 25. But the savings from that earlier intervention do not show up in the OB/GYN line. They show up in endocrinology, cardiology, and population health, years later, in a different budget cycle, attributed to a different department.</p>
      <p>Women live longer than men but spend more time in poor health. Working women in the United States spend an average of 18% more on healthcare than men while experiencing 25% more time in poor health. That utilization pattern is a direct consequence of diagnostic gaps and undertreated conditions. And every dollar of it flows through health systems.</p>

      <h2>The Three ROI Drivers Health Systems Must Quantify</h2>

      <h2>1. Reduced Long-Term Utilization Through Earlier Diagnosis</h2>
      <p>PCOS alone costs the U.S. healthcare system $8 billion annually. The majority of that cost is concentrated in the long-term management of metabolic complications, including diabetes, cardiovascular disease, and stroke, that develop when PCOS goes undiagnosed or undertreated for years. Earlier diagnosis does not just improve patient outcomes. It reduces the downstream utilization that drives your highest-cost chronic disease spend.</p>
      <p>The same logic applies to endometriosis, autoimmune conditions, and cardiovascular disease in women. Each year of diagnostic delay is a year of unmanaged disease progression accumulating cost in your system.</p>

      <h2>2. Workforce Retention and Provider Satisfaction</h2>
      <p>OB/GYN is one of the most at-risk specialties for physician burnout and attrition. The administrative burden created by poorly optimized EHR workflows, documentation-heavy clinical environments, and under-resourced women's health service lines is directly contributing to turnover in a specialty already facing a significant workforce shortage.</p>
      <p>Physician burnout costs the U.S. healthcare system an estimated $4.6 billion annually in turnover and reduced productivity. Epic Stork workflow optimization, clinical readiness investments, and femtech tools that genuinely reduce documentation burden are not technology expenses. They are retention investments.</p>

      <h2>3. Patient Acquisition and Loyalty in a High-Value Demographic</h2>
      <p>Women make approximately 80% of household healthcare decisions. When a woman has a positive clinical experience in your system, she does not just return. She directs her family's care, influences her employer's health plan choices, and becomes one of the most reliable patient loyalty drivers in your entire population.</p>
      <p>Health systems that build a strong women's health reputation, supported by excellent clinical outcomes, modern technology, and culturally competent care, are investing in patient acquisition across every service line, not just OB/GYN. The lifetime value of a woman who trusts your health system is not captured in a single encounter.</p>

      <h2>What the Investment Case Looks Like for Health Systems</h2>
      <p>Unlike pharmaceutical or venture capital investment, health system ROI in women's health is built across three horizons:</p>
      <p><strong>Near-term (0 to 12 months):</strong> Epic optimization and clinical workflow improvements that reduce documentation time, improve provider satisfaction scores, and decrease after-hours charting. These have measurable impact on retention cost and burnout rates within a single fiscal year.</p>
      <p><strong>Mid-term (12 to 36 months):</strong> Femtech deployment in high-priority service lines that improves care navigation, closes postpartum follow-up gaps, and supports earlier diagnosis of conditions like PCOS and endometriosis. These investments reduce emergency utilization and improve quality metrics tied to value-based care contracts.</p>
      <p><strong>Long-term (36 months and beyond):</strong> Population health improvements in chronic disease incidence, maternal outcomes, and preventable hospitalization rates among the women in your attributed patient population. These are the numbers that move your CMS star ratings, your ACO performance, and your payer negotiations.</p>

      <h2>The Competitive Window Is Narrowing</h2>
      <p>VC investment in women's health grew by 55% in 2024, representing more than $1 billion in new capital entering the sector. Femtech companies are building enterprise-ready platforms at a pace that was not possible three years ago. The health systems that partner with the right solutions now, with the right clinical readiness infrastructure in place, will own the women's health patient relationship in their markets for the next decade.</p>
      <p>The systems that wait will be acquiring patients from competitors who did not.</p>
      <blockquote>Improving women's health outcomes could add at least $1 trillion to global GDP annually and unlock $400 billion through reduced healthcare expenses, enhanced workforce participation, and increased productivity. That is not a projection designed to inspire a conference keynote. It is a financial argument designed to clear a budget committee.</blockquote>

      <h2>How The Faulkner Group Helps You Build the Case</h2>
      <p>The Faulkner Group works with health system leaders to build the operational and clinical infrastructure that makes women's health investment perform. From Epic Stork optimization to femtech clinical readiness and advisory partnership, we help you close the gap between strategic intent and measurable financial outcomes.</p>
      <p>If you are ready to take the women's health business case to your leadership team, start with a Clinical Clarity Session and let us help you build the numbers.</p>
      <p style="margin-top: 2rem; display: flex; gap: 1rem; flex-wrap: wrap;">
        <a href="/clinical-clarity-session" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Book Your Clinical Clarity Session</a>
        <a href="/clinical-readiness-roadmap" style="display: inline-block; border: 1px solid #C9A84C; color: #C9A84C; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Download the Clinical Readiness Roadmap</a>
      </p>
    `,
  },
  {
    slug: "how-to-evaluate-femtech-vendor",
    title: "How to Evaluate a Femtech Vendor: What Health Systems Need to Ask Before Signing",
    excerpt:
      "Most health systems evaluate femtech vendors the wrong way. They evaluate the product. They should be evaluating the partnership.",
    category: "Health System Strategy",
    date: "January 22, 2026",
    readTime: "14 min read",
    image: articleFemtechVendor,
    content: `
      <p>Most health systems evaluate femtech vendors the wrong way.</p>
      <p>They evaluate the product. They should be evaluating the partnership.</p>
      <p>A femtech solution that performs beautifully in a controlled demo can fail completely in a live clinical environment. Not because the technology was misrepresented, but because the questions that determine real-world success were never asked during the evaluation process. By the time the gaps surface, the contract is signed, the go-live date is set, and the clinical team is already frustrated.</p>
      <p>This is fixable. But it requires a different evaluation framework, one built around clinical deployment reality rather than feature lists and pitch decks.</p>

      <h2>Why Standard Vendor Evaluation Falls Short in Women's Health</h2>
      <p>Femtech occupies a unique position in the healthcare vendor landscape. It operates at the intersection of consumer health technology, clinical care, and a patient population that has historically been underserved by both. The solutions are often founder-led, mission-driven companies building products for conditions that established health IT vendors ignored entirely.</p>
      <p>That is a strength. It is also a risk factor for health systems that apply generic SaaS procurement criteria to clinical deployment decisions.</p>
      <p>Standard vendor evaluation focuses on security certifications, pricing, and feature parity. Those things matter. But they do not answer the questions that determine whether a femtech tool will actually be used by your clinical team, trusted by your patients, and sustainable inside your EHR environment 18 months after go-live.</p>
      <p>The femtech sector is maturing fast. In 2026, health system buyers have more options, more data on what works, and more regulatory guidance than ever before. The evaluation process needs to mature at the same pace.</p>

      <h2>The 7 Questions Every Health System Must Ask Before Signing</h2>

      <h2>1. How does this solution integrate with our EHR, and who owns the integration work?</h2>
      <p>This is the first question and the most important one. Femtech tools that exist outside the clinical workflow are tools that clinicians will not use. Ask specifically how the solution integrates with Epic, Oracle Health, or whatever platform your system runs. Ask who builds the integration, who tests it, who maintains it after go-live, and what happens when Epic releases an upgrade that breaks it.</p>
      <blockquote>If the vendor cannot answer those questions with specificity, the integration is not ready. And an unintegrated femtech solution is a liability to your clinical team, not an asset.</blockquote>

      <h2>2. What does your implementation process look like, and who is on your implementation team?</h2>
      <p>Implementation is where femtech pilots fail. Ask for a detailed implementation timeline, the specific roles on the vendor's implementation team, and examples of comparable deployments at health systems of similar size and complexity. Ask what the vendor does if a go-live is delayed. Ask what the first 90 days of support look like.</p>
      <p>A vendor that leads with product features and struggles to describe their implementation process with confidence is telling you something important.</p>

      <h2>3. How was your clinical content developed, and by whom?</h2>
      <p>Women's health is a clinical specialty with specific guidelines, nuanced symptom profiles, and an evidence base that evolves rapidly. ACOG published its first comprehensive endometriosis diagnostic guidance in February 2026. The clinical content inside your femtech solution needs to reflect current evidence, not the evidence base from the year the product was built.</p>
      <p>Ask whether clinical content was developed with board-certified specialists. Ask how often it is reviewed and updated. Ask who holds clinical accountability for the guidance embedded in the platform.</p>

      <h2>4. How does your solution address health equity?</h2>
      <p>If a femtech tool was built primarily on data from one demographic, it will perform unevenly across your patient population. This is not a theoretical concern. AI models trained without race-disaggregated data produce recommendations that are less accurate for the populations that already face the worst outcomes.</p>
      <blockquote>Ask for outcome data segmented by patient demographics. Ask whether the solution has been validated in racially and socioeconomically diverse populations. If the vendor does not have that data, that is your answer.</blockquote>

      <h2>5. What does success look like at 6, 12, and 24 months, and how is it measured?</h2>
      <p>Every vendor will tell you their solution improves outcomes. Ask them to define which outcomes, by how much, measured how, and over what time period. Ask for customer references at health systems that have used the solution for more than 12 months and ask those references whether the vendor's outcome claims matched reality.</p>
      <p>Health systems that define success metrics before signing are the ones that generate the data they need to justify renewal and expansion. Vendors that resist defining metrics early are telling you something about what their data actually shows.</p>

      <h2>6. What is your reimbursement strategy, and how does it apply to our payer mix?</h2>
      <p>A femtech solution that cannot be reimbursed is a cost center, not a revenue driver. Reimbursement in women's health is complex, varies by payer, and in many cases is still being established for newer digital health modalities. Ask the vendor specifically how their solution generates or supports reimbursement in your market and with your payer contracts.</p>
      <p>If the answer is "we are still working on it," factor that into your timeline and budget expectations accordingly.</p>

      <h2>7. What does your post go-live support model look like?</h2>
      <p>Go-live is not the end of the implementation. It is the beginning of the adoption phase, which is where most femtech deployments either succeed or quietly fail. Ask what dedicated support the vendor provides in the first 90 days. Ask how they handle workflow issues surfaced by clinical staff after go-live. Ask whether they have a customer success function or whether support is handled by a general helpdesk.</p>
      <blockquote>A vendor that disappears after go-live has not delivered a clinical solution. They have delivered a product. Those are not the same thing.</blockquote>

      <h2>Red Flags to Watch For</h2>
      <p>Beyond the formal questions, health system evaluators should watch for the following patterns during vendor evaluation:</p>
      <ul>
        <li>The demo shows a polished UI but the vendor cannot describe the data model or clinical logic underneath it</li>
        <li>The implementation timeline is described in weeks for a deployment that realistically requires months</li>
        <li>References provided are all from direct-to-consumer or employer health contexts, with no health system deployments at scale</li>
        <li>The vendor cannot name a specific clinical leader who holds accountability for the platform's evidence base</li>
        <li>Equity and demographic validation data are described as "in development" or "coming soon"</li>
        <li>The pricing model changes significantly between the initial conversation and the formal proposal without a clear explanation</li>
      </ul>

      <h2>Build a Clinical Readiness Evaluation Into Every Vendor Process</h2>
      <p>The questions above evaluate the vendor. But they only work if your health system is also evaluating itself honestly.</p>
      <p>A femtech solution can have excellent EHR integration, a rigorous implementation team, and peer-reviewed clinical content and still fail inside a health system that is not operationally ready to receive it. Clinical champion identification, workflow redesign, staff training, and outcome measurement frameworks are health system responsibilities, not vendor responsibilities.</p>
      <blockquote>The most successful femtech partnerships in 2026 are the ones where both sides did their preparation work. The vendor arrived ready to implement and the health system arrived ready to integrate.</blockquote>
      <p>That dual readiness is not accidental. It is built.</p>

      <h2>How The Faulkner Group Supports Your Evaluation Process</h2>
      <p>The Faulkner Group works with health systems at every stage of femtech vendor evaluation and deployment. We help clinical and operational leaders ask the right questions before signing, identify the internal readiness gaps that will determine deployment success, and build the workflow and training infrastructure that turns a vendor agreement into a clinical result.</p>
      <p>If you have a femtech evaluation underway or a recent deployment that is not performing as expected, a Clinical Clarity Session is the fastest way to identify where the gap is and what to do about it.</p>
      <p style="margin-top: 2rem; display: flex; gap: 1rem; flex-wrap: wrap;">
        <a href="/clinical-clarity-session" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Book Your Clinical Clarity Session</a>
        <a href="/clinical-readiness-assessment" style="display: inline-block; border: 1px solid #C9A84C; color: #C9A84C; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Download the Clinical Readiness Assessment</a>
      </p>
    `,
  },
  {
    slug: "americas-maternal-health-crisis-2026",
    title: "America's Maternal Health Crisis in 2026: The Data, The Gaps, and What Must Change",
    excerpt:
      "A woman in the United States is more likely to die from pregnancy or childbirth today than her mother was a generation ago. That sentence should stop every health system leader in their tracks.",
    category: "Maternal Health",
    date: "March 2, 2026",
    readTime: "16 min read",
    image: articleMaternalHealth,
    content: `
      <p>A woman in the United States is more likely to die from pregnancy or childbirth today than her mother was a generation ago.</p>
      <p>That sentence should stop every health system leader in their tracks. It has not stopped enough of them.</p>
      <p>In March 2026, the CDC released its final maternal mortality data for 2024. The headline number was 17.9 deaths per 100,000 live births, a slight decrease from 18.6 in 2023. That marginal improvement was not statistically significant. And buried inside those numbers is a reality that no single headline captures: the United States maternal health crisis is not improving at a pace that reflects the resources, technology, and clinical knowledge available to us right now.</p>
      <p>This is not a data problem. It is a will problem. And health systems are the ones with the authority to change it.</p>

      <h2>The Numbers Health Systems Need to Own</h2>
      <p>In 2024, 649 women died of maternal causes in the United States. That number, held up against the maternal mortality rates of peer nations, is not a statistical artifact. It is an indictment of how this country has chosen to fund, design, and deliver obstetric care.</p>
      <blockquote>The United States has the highest maternal mortality rate among developed nations.</blockquote>
      <p>Louisiana's maternal mortality rate is more than four times California's. Mississippi's infant mortality rate is nearly triple Massachusetts'. The variance is not genetic. It is structural. It is the product of state-level policy choices about Medicaid, reproductive health services, and social support infrastructure.</p>
      <p>Women aged 40 and older face a maternal mortality rate of 62.3 per 100,000 live births, more than four times the rate for women under 25. As more women delay pregnancy for professional and financial reasons, and as the average age of first-time mothers in the United States continues to rise, this risk profile demands a clinical response that most health systems have not yet built.</p>

      <h2>The Racial Disparity That Cannot Be Explained Away</h2>
      <p>Black women in the United States die from maternal causes at a rate of 44.8 per 100,000 live births. White women die at a rate of 14.2. That is a 3x gap. It has persisted across decades of data, across income levels, across educational attainment, and across geography.</p>
      <blockquote>Black maternal mortality in the United States resembles that of Grenada, Honduras, Vietnam, and Brazil. In Louisiana, outcomes for Black mothers mirror those of Mexico.</blockquote>
      <p>These are not comparisons that reflect well on the most resourced healthcare system in the world.</p>
      <p>The CDC's 2023 data showed that Black pregnancy was the only demographic group to see an increase in death rates year over year. The 2024 data showed a slight decrease that was not statistically significant. In a country with the infrastructure, the clinical evidence base, and the technology to prevent these deaths, a pattern this persistent is not a coincidence. It is a system design outcome.</p>
      <p>Approximately 84% of pregnancy-related deaths in the United States are preventable, according to the CDC. Not addressable. Not reducible. Preventable. That word matters. It means the decisions that would change these outcomes already exist. They are just not being made consistently, equitably, or urgently enough.</p>

      <h2>The Access Crisis Hiding Behind the Mortality Data</h2>
      <p>Maternal mortality is the most visible edge of a much wider access failure. Maternity care deserts, defined as counties with no hospital-based obstetric care and no obstetric provider, affect millions of American women, concentrated in rural communities and low-income urban areas.</p>
      <p>An estimated 24% of urban areas report having no clinical obstetrician. Rural maternal death rates surged 74% during the pandemic and have not fully recovered. The AMA reports that many rural hospitals are operating in the red, with inpatient obstetric units among the first services to be cut when financial pressure forces consolidation.</p>
      <p>Persistent gaps in access to care, patient education, postpartum support, and mental health resources continue to shape women's maternal experiences in 2026. The postpartum window, specifically the 12 months following delivery, is where a significant portion of preventable deaths occur and where clinical follow-through remains systemically weak.</p>
      <blockquote>A woman who delivers safely and then dies of a postpartum complication did not survive her pregnancy. She was failed by the infrastructure that should have caught her on the other side of it.</blockquote>

      <h2>What Technology Can and Cannot Fix</h2>
      <p>Femtech and digital health solutions targeting maternal care are advancing rapidly. Remote patient monitoring tools, AI-driven risk stratification platforms, and maternal health navigation apps are entering health system partnerships with the genuine potential to extend care into underserved geographies, identify high-risk pregnancies earlier, and close postpartum follow-up gaps.</p>
      <p>But technology deployed into a clinically unprepared system does not close the maternal health gap. It adds a layer of complexity to an already strained environment. A remote monitoring platform that flags a postpartum hypertension alert only improves outcomes if the clinical workflow on the receiving end is designed to respond to that alert quickly and correctly.</p>
      <p>The same logic applies to Epic Stork optimization. OB/GYN teams managing high volumes of maternal patients in under-resourced environments need documentation workflows that reduce cognitive burden, not add to it. Postpartum care checklists need to be embedded in the workflow, not filed in a separate module that requires a separate login at the end of a 12-hour shift.</p>

      <h2>What Health Systems Must Do Right Now</h2>
      <p>The data is not new. The interventions are not mysterious. What is missing is the operational commitment to implement them consistently across every patient, every demographic, and every zip code served.</p>
      <p>Health systems that are serious about maternal health outcomes in 2026 must take the following steps:</p>
      <ul>
        <li>Audit postpartum follow-up rates by patient demographic and identify where Black and high-risk patients are falling out of care between delivery and the 6-week visit</li>
        <li>Build structured postpartum depression and hypertension screening protocols directly into Epic Stork workflows so they are triggered automatically, not left to individual clinician discretion</li>
        <li>Evaluate maternal health navigation and remote monitoring tools through a formal clinical readiness process before deployment, not after</li>
        <li>Train every clinician who interacts with pregnant and postpartum women to recognize the early warning signs of hemorrhage, hypertension, and sepsis, the three leading causes of preventable maternal death in the United States</li>
        <li>Establish race and ethnicity disaggregated maternal outcome data as a standing quality metric reviewed at the leadership level, not buried in an annual report</li>
      </ul>

      <h2>The System Is the Risk Factor</h2>
      <p>The most important insight in the 2024 CDC maternal mortality data is not the number. It is what the number reveals about where responsibility sits.</p>
      <p>Women aged 40 and older do not need to be told their pregnancy is high risk. They need a health system that is actually built to manage it. Black women do not need more awareness campaigns. They need obstetricians who listen to them, workflows that capture their symptoms accurately, and postpartum care that follows them home.</p>
      <blockquote>The maternal health crisis is not a patient failure. It is a system failure. And the health system leaders reading this article have more influence over the next set of CDC numbers than any individual patient ever will.</blockquote>
      <p>That is not a burden. It is an opportunity.</p>

      <h2>How The Faulkner Group Helps</h2>
      <p>The Faulkner Group works with health systems to build the clinical and operational infrastructure that maternal health demands. From Epic Stork workflow optimization to clinical readiness assessment for maternal health technology, we help health systems move from awareness to action.</p>
      <p>If your organization is ready to take measurable steps toward better maternal outcomes, start with a Clinical Clarity Session.</p>
      <p style="margin-top: 2rem; display: flex; gap: 1rem; flex-wrap: wrap;">
        <a href="/clinical-clarity-session" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Book Your Clinical Clarity Session</a>
        <a href="/clinical-readiness-roadmap" style="display: inline-block; border: 1px solid #C9A84C; color: #C9A84C; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Explore the Clinical Readiness Roadmap</a>
      </p>
    `,
  },
  {
    slug: "real-cost-womens-health-misdiagnosis-2026",
    title: "The Real Cost of Women's Health Misdiagnosis in 2026",
    excerpt:
      "Women are not getting sicker. They are getting ignored longer. And the healthcare system is paying a price it refuses to calculate.",
    category: "Women's Health",
    date: "January 27, 2026",
    readTime: "14 min read",
    image: articleMisdiagnosis,
    content: `
      <p>Women are not getting sicker. They are getting ignored longer.</p>
      <p>And the healthcare system is paying a price it refuses to calculate.</p>
      <p>Misdiagnosis in women's health is not a rare occurrence. It is not an edge case. It is a structural failure built into how medicine was designed, how clinical training was standardized, and how pain has been evaluated differently depending on who is reporting it. In 2026, with more data, more technology, and more clinical guidance than at any point in history, women are still waiting years for answers that should take weeks.</p>
      <p>That delay has a cost. A human one. And a financial one that should alarm every health system leader, payer, and femtech founder paying attention.</p>

      <h2>The Numbers That Cannot Be Ignored</h2>
      <blockquote>Women's health receives only 6% of global health research and innovation funding, despite women representing nearly 50% of the world's population.</blockquote>
      <p>The McKinsey Health Institute estimates that closing the women's health gap represents a $1 trillion opportunity to improve lives and economic productivity globally. A separate analysis puts the addressable gap at $360 billion in the United States alone.</p>
      <p>These are not funding arguments. They are diagnostic arguments. When an entire category of healthcare is systematically underfunded, underresearched, and undertreated, the result is a patient population that is chronically misdiagnosed. And chronic misdiagnosis is not free. It shows up in emergency visits, repeat hospitalizations, duplicated diagnostics, delayed treatment costs, and lost workforce productivity. It just gets accounted for in the wrong column.</p>

      <h2>The Conditions Carrying the Highest Cost</h2>

      <h2>Endometriosis</h2>
      <p>Endometriosis affects 1 in 10 women of reproductive age worldwide. The average time to diagnosis ranges from 4 to 11 years. During those years, women are told they have irritable bowel syndrome, anxiety, or simply "bad periods." They are cycled through primary care, gastroenterology, and mental health referrals before anyone considers their reproductive system as the source of the problem.</p>
      <blockquote>The financial cost of that delay is $78 billion annually in healthcare expenditures and lost productivity.</blockquote>
      <p>That figure does not account for the cost of surgical procedures performed for misdiagnosed conditions, the mental health sequelae of years of invalidated pain, or the fertility outcomes that deteriorate while the clock runs.</p>
      <p>On February 16, ACOG published its first comprehensive diagnostic guidance for endometriosis, Clinical Practice Guideline 11, allowing clinicians to make a presumptive diagnosis based on symptoms and clinical history without requiring surgical confirmation. That is a landmark shift. But a guideline only changes outcomes when health systems operationalize it. Most have not.</p>

      <h2>PCOS</h2>
      <p>Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting an estimated 8 to 13% of women globally. It is also one of the most frequently misdiagnosed. Women with PCOS are commonly told they have thyroid disorders, depression, or weight management issues before the correct diagnosis is made. The average diagnostic delay ranges from 2 to 7 years.</p>
      <p>PCOS has documented links to type 2 diabetes, cardiovascular disease, endometrial cancer, and infertility. Each year of delayed diagnosis is a year of unmanaged metabolic risk accumulating without intervention.</p>

      <h2>Cardiovascular Disease</h2>
      <p>Heart disease is the leading cause of death in women in the United States. It kills more women annually than all forms of cancer combined. And yet women having a cardiac event are significantly more likely than men to be sent home from the emergency department, to be told their symptoms are anxiety, and to experience a second event before receiving a correct diagnosis.</p>
      <p>The clinical literature on this is not new. The pattern is. Because it has not changed.</p>

      <h2>Autoimmune Conditions</h2>
      <p>Nearly 80% of autoimmune disease patients are women. The average time to diagnosis for conditions like lupus, multiple sclerosis, and rheumatoid arthritis in women ranges from 4 to 6 years. During that time, symptoms are frequently attributed to stress, hormones, or mental health. The downstream cost of late-stage autoimmune disease treatment versus early intervention is significant both clinically and financially.</p>

      <h2>Why This Keeps Happening</h2>
      <p>The answer is structural, not individual.</p>
      <p>Medical research historically excluded women from clinical trials. The assumption that male physiology was the default standard meant that diagnostic criteria, symptom checklists, and treatment protocols were built on data that did not represent half the population. Women's symptoms were then evaluated against that incomplete standard and found inconclusive. Inconclusive became dismissed.</p>
      <blockquote>Women are 50% more likely than men to be misdiagnosed following a heart attack.</blockquote>
      <p>Women with pain conditions wait an average of 65 minutes for analgesic treatment in emergency settings compared to 49 minutes for men presenting with the same conditions. Women reporting chronic pain are more likely to receive a mental health referral than a diagnostic workup.</p>
      <p>This is not anecdote. This is pattern. And patterns are systemic by definition.</p>
      <p>Approximately 50% of women skip or delay necessary care due to a combination of cost, access barriers, and prior negative experiences in the healthcare system. When the system teaches women that their symptoms will not be believed, they stop reporting them. That silence is not wellness. It is a suppressed dataset that makes population health outcomes worse for everyone.</p>

      <h2>The Role of Technology in Closing the Gap</h2>
      <p>The women's digital health market is projected to exceed $13 billion by 2033. Femtech solutions targeting earlier detection, symptom tracking, hormone monitoring, and condition-specific care navigation are entering the market faster than health systems can evaluate them.</p>
      <p>AI-driven diagnostic tools trained on sex-disaggregated data have the potential to identify endometriosis, PCOS, and cardiovascular risk patterns years earlier than current standard-of-care pathways. The World Economic Forum launched the Women's Health Infrastructure Tracker in January 2026 specifically to build the global data architecture needed to make AI equitable in women's health.</p>
      <p>But technology cannot close this gap alone. A symptom-tracking app deployed into a clinical environment where the provider has not been trained to use the data it generates is not a solution. It is a feature. The solution requires clinical readiness, workflow integration, provider education, and organizational commitment to treating women's symptoms as diagnostic signals rather than psychological noise.</p>

      <h2>What Health Systems Must Do Now</h2>
      <p>The case for action is not just ethical. It is financial. A woman who is correctly diagnosed with endometriosis in year one costs the system a fraction of what she costs in year seven. A PCOS diagnosis at 24 versus 31 changes her metabolic trajectory, her fertility outcomes, and her lifetime utilization of healthcare resources. A cardiac event caught in the ED rather than at the second presentation is a different actuarial outcome entirely.</p>
      <p>Health systems that want to lead in women's health in 2026 must:</p>
      <ul>
        <li>Adopt and operationalize ACOG Clinical Practice Guideline 11 for endometriosis diagnosis across all relevant service lines, not just OB/GYN</li>
        <li>Train every clinical role that interacts with women of reproductive age to recognize and document the symptom patterns of PCOS, endometriosis, and autoimmune conditions</li>
        <li>Audit their EHR documentation templates to ensure symptom capture for women's health conditions is structured, not buried in free text</li>
        <li>Evaluate femtech solutions for their ability to surface diagnostic signals earlier and integrate them into clinical workflow through a formal clinical readiness process</li>
        <li>Track diagnostic timelines by condition and by patient demographic as a quality metric, not just an anecdotal concern</li>
      </ul>

      <h2>The Belief Problem Is a System Problem</h2>
      <p>The endometriosis post that The Faulkner Group published in early 2026 said it plainly: we do not have a detection problem. We have a belief problem.</p>
      <p>That is true. And belief problems do not get solved with better apps or faster EHR builds. They get solved when clinical leaders decide that women's symptoms are as worth investigating as anyone else's. They get solved when diagnostic protocols stop treating women's pain as a secondary signal. And they get solved when health systems build the operational infrastructure to act on what the evidence has been saying for decades.</p>
      <blockquote>Women's healthcare is not a niche. It is not a specialty silo. It is the center of population health strategy for any system that treats human beings across a lifespan.</blockquote>
      <p>The cost of getting it wrong is already on your balance sheet. You just have not labeled it correctly yet.</p>

      <h2>Work With The Faulkner Group</h2>
      <p>The Faulkner Group works with health systems and femtech companies to build the operational and clinical infrastructure that women's health demands. From clinical readiness assessments to Epic Stork optimization to femtech adoption strategy, we close the gap between what health systems intend and what patients actually experience.</p>
      <p>If your organization is ready to treat women's health as the strategic priority it is, start with a Clinical Clarity Session.</p>
      <p style="margin-top: 2rem; display: flex; gap: 1rem; flex-wrap: wrap;">
        <a href="/clinical-clarity-session" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Book Your Clinical Clarity Session</a>
        <a href="/clinical-readiness-roadmap" style="display: inline-block; border: 1px solid #C9A84C; color: #C9A84C; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Download the Clinical Readiness Roadmap</a>
      </p>
    `,
  },
  {
    slug: "epic-stork-optimization-obgyn",
    title: "Epic Stork Optimization: How OB/GYN Teams Reclaim Time at the Bedside",
    excerpt:
      "Your OB/GYN team did not choose medicine to spend their shift in a documentation queue. Here is how optimizing Epic Stork gives clinicians back the time they need at the bedside.",
    category: "EHR Optimization",
    date: "November 11, 2025",
    readTime: "12 min read",
    image: articleEpicStork,
    content: `
      <p>Your OB/GYN team did not choose medicine to spend their shift in a documentation queue.</p>
      <p>But for most labor and delivery units running Epic Stork, that is exactly what is happening.</p>
      <p>Epic Stork is one of the most powerful obstetric care modules available in healthcare IT today. It is designed to manage the full continuum of women's health care, from the first prenatal visit through labor and delivery and into the postpartum period. When it is built well and configured to reflect how care actually happens, it reduces documentation burden, improves care coordination, and gives clinicians the time and focus they need to practice at the top of their license.</p>
      <blockquote>When it is built poorly, it becomes the reason your best physicians are burning out.</blockquote>

      <h2>What Epic Stork Actually Does</h2>
      <p>Epic Stork is Epic's dedicated obstetric care module, built to support prenatal record management, labor and delivery workflows, fetal monitoring integration, newborn management, postnatal care tracking, and patient engagement through MyChart.</p>
      <p>It integrates across the Epic ecosystem, connecting OB/GYN workflows with nursing, anesthesia, neonatology, laboratory, radiology, and revenue cycle in a single clinical environment. When those integrations are configured correctly, care teams operate from one shared source of truth. When they are not, teams resort to workarounds, verbal relays, and duplicate documentation that introduces both inefficiency and error.</p>
      <p>The difference between those two outcomes is almost never the software. It is the build.</p>

      <h2>The Hidden Cost of a Poor Stork Build</h2>
      <p>Most health systems implement Epic Stork and then leave it largely untouched for years. They go live, they move on, and the clinical team adapts to whatever configuration was handed to them, even when that configuration was built for a generic workflow rather than their specific population, practice patterns, or staffing model.</p>
      <p>The result is what clinicians describe as "note bloat": excessive mandatory fields, SmartForms that do not match how clinicians think, and Order Sets that require ten clicks to accomplish what should take two. Documentation that should take 8 minutes takes 22. Shift notes bleed into personal time. Cognitive load accumulates. And eventually, good clinicians leave.</p>
      <blockquote>Physician burnout is estimated to cost the U.S. healthcare system $4.6 billion annually in turnover, recruitment, and reduced productivity.</blockquote>
      <p>In OB/GYN, a specialty already facing a growing workforce shortage, the margin for documentation inefficiency is zero.</p>

      <h2>What Optimized Epic Stork Looks Like</h2>
      <p>An optimized Epic Stork environment is built around how your clinical team actually practices, not around a default configuration that Epic shipped with the implementation.</p>
      <p>Optimization means:</p>
      <ul>
        <li>SmartForms designed to match the cognitive sequence of a real prenatal visit, not an administrative checklist</li>
        <li>SmartPhrases that reduce free-text documentation without sacrificing clinical nuance</li>
        <li>Flowsheets that capture labor progression intuitively, so nurses spend time at the bedside, not at the keyboard</li>
        <li>Order Sets aligned with current ACOG guidelines, reviewed by actual OB/GYNs, and updated on a defined change control schedule</li>
        <li>Fetal monitoring integration that displays heart rate and contraction patterns directly in the patient chart without requiring a separate login or manual data transfer</li>
        <li>Role-based views so a labor and delivery nurse, a certified nurse midwife, and a perinatologist each see exactly what they need without sorting through what they do not</li>
      </ul>
      <p>When these elements are in place, Epic Stork does what it was designed to do. It removes friction from care delivery so clinicians can focus on the patient in the room.</p>

      <h2>The Optimization Process: What It Involves</h2>
      <p>Optimizing Epic Stork is not a one-time project. It is a discipline. But it starts with a clear-eyed audit of where your current build is creating friction and where the highest-value improvements live.</p>

      <h2>Step 1: Workflow Discovery</h2>
      <p>This means sitting with your clinical team, not just reviewing build documentation. Understanding how an OB hospitalist actually documents an emergent delivery is different from understanding the theoretical workflow in the system. Discovery surfaces the gap between what was built and what is actually used.</p>

      <h2>Step 2: Gap Analysis</h2>
      <p>Once workflows are mapped, the gaps become visible. Missing SmartPhrases. Order Sets that have not been touched since go-live. Flowsheets with redundant fields. Documentation requirements that exist because someone asked for them years ago and no one removed them. Gap analysis turns clinical frustration into an actionable build roadmap.</p>

      <h2>Step 3: Clinician-Informed Build</h2>
      <p>Every build decision should be validated by a clinician who practices in the specialty. This is the step most IT-led optimization projects skip. A technically correct build that does not reflect real clinical practice will not be adopted. Full stop.</p>

      <h2>Step 4: Role-Specific Training</h2>
      <p>Updated builds require updated training. And that training must be designed for the specific role, not the department. A postpartum nurse and a maternal fetal medicine specialist interact with Stork differently. Training that treats them the same produces adoption rates that reflect that lack of care.</p>

      <h2>Step 5: Go-Live Support and Ongoing Governance</h2>
      <p>The optimization is not complete at go-live. A monthly change control schedule, proactive Epic enhancement adoption, and Gold Stars program participation are what separate organizations that continuously improve from those that stagnate between implementations.</p>

      <h2>Who This Is For</h2>
      <p>Epic Stork optimization is the right investment if your health system is experiencing any of the following:</p>
      <ul>
        <li>OB/GYN providers reporting documentation fatigue or excessive after-hours charting</li>
        <li>Low Epic adoption scores or usage rates in the women's health service line</li>
        <li>A recent or upcoming Epic upgrade that requires workflow redesign</li>
        <li>A new women's health service line or facility that needs a tailored Stork build</li>
        <li>Post-go-live regret where the implementation delivered a technically functional system but clinical teams are not using it effectively</li>
      </ul>
      <p>If any of those sound familiar, the issue is almost certainly not your team. It is the build they were handed.</p>

      <h2>The Faulkner Group Approach to Stork Optimization</h2>
      <p>The Faulkner Group specializes exclusively in Epic optimization for Women's Health. Our work is led by an Epic-certified consultant with over 14 years of experience across Stork, ClinDoc, and Ambulatory, working in close partnership with a board-certified OB/GYN who brings 10 years of clinical practice to every build decision.</p>
      <p>We do not optimize in the abstract. We build what your clinicians will actually use, designed around how care happens in your system, validated by someone who has delivered babies and documented in Epic at the same time.</p>
      <p>The goal is simple: reduce the burden, give providers more time with their patients, and help them reconnect with why they became clinicians in the first place.</p>
      <p>If your team is surviving Epic instead of thriving in it, that is the problem we solve.</p>
      <p style="margin-top: 2rem;">
        <a href="https://calendly.com/d/cx9v-b5q-nhp/let-s-meet-john-dr-nicole-faulkner" target="_blank" rel="noopener noreferrer" style="display: inline-block; background: #C9A84C; color: #0f1a2e; padding: 12px 24px; border-radius: 8px; font-weight: 600; text-decoration: none;">Schedule a Discovery Call</a>
      </p>
    `,
  },
  {
    slug: "what-is-clinical-readiness-womens-health",
    title: "What Is Clinical Readiness in Women's Health and Why Most Health Systems Don't Have It",
    excerpt:
      "Health systems do not have a technology problem in women's health. They have a readiness problem. And most of them do not know it until a deployment fails.",
    category: "Clinical Strategy",
    date: "September 23, 2025",
    readTime: "10 min read",
    image: articleClinicalReadiness,
    content: `
      <p>Health systems do not have a technology problem in women's health.</p>
      <p>They have a readiness problem. And most of them do not know it until a deployment fails.</p>
      <p>The term "clinical readiness" gets used loosely in healthcare IT circles. It shows up in implementation timelines, vendor proposals, and go-live checklists. But it rarely gets defined with the specificity that women's health requires. That ambiguity is costing health systems real money, real time, and real trust from the clinicians they are trying to support.</p>

      <h2>Defining Clinical Readiness</h2>
      <blockquote>Clinical readiness is the operational and clinical state a health system must reach before a new technology, workflow, or care model can be deployed safely, sustainably, and effectively.</blockquote>
      <p>It is not a checklist. It is not a go-live date. It is not IT approval.</p>
      <p>Clinical readiness means your people know what they are doing, your systems are configured to support them, your workflows reflect how care actually happens, and your leadership is aligned on what success looks like before a single patient encounter occurs.</p>
      <p>In women's health specifically, clinical readiness requires an additional layer of intentionality. OB/GYN workflows span prenatal, intrapartum, and postpartum care across multiple departments, multiple clinician types, and often multiple facilities. A gap in readiness at any one of those points creates a ripple effect that touches patient safety, provider satisfaction, and clinical outcomes.</p>

      <h2>What Clinical Readiness Is Not</h2>
      <p><strong>It is not a software upgrade.</strong> A new Epic module or a femtech integration does not make a health system clinically ready. It adds capability. Readiness is what determines whether that capability gets used.</p>
      <p><strong>It is not a training session.</strong> A two-hour onboarding does not prepare a labor and delivery nurse for a new fetal monitoring workflow any more than a slideshow prepares a surgeon for a new OR. Role-specific, scenario-based preparation is what moves information into practice.</p>
      <p><strong>It is not a signed contract.</strong> Agreements between health systems and technology vendors signal intent, not readiness. The gap between a signed agreement and a successful go-live is exactly where most implementations fall apart.</p>

      <h2>The 5 Dimensions of Clinical Readiness in Women's Health</h2>
      <p>A health system is clinically ready when it has addressed all five of the following dimensions before deployment begins.</p>

      <h2>1. Workflow Alignment</h2>
      <p>Every clinical workflow touched by the new technology must be mapped in its current state and redesigned in its future state before a single build is done. This means understanding how an OB/GYN documents a prenatal visit today, where the friction points are, and how the new solution reduces rather than adds to that burden.</p>

      <h2>2. EHR Integration</h2>
      <p>In women's health, this primarily means Epic (EHR) - Women's Health, ClinDoc, and Ambulatory. The integration must be scoped, tested, and validated before go-live. An unintegrated tool is a tool clinicians will not use. And a tool clinicians do not use is a liability, not an asset.</p>

      <h2>3. Clinician Champions</h2>
      <p>Not every physician who expresses interest in a new tool is a clinical champion. A true champion has positional authority, workflow credibility with their peers, and the capacity to drive adoption through example. Health systems that identify champions late in the process consistently see lower adoption rates.</p>

      <h2>4. Staff Training by Role</h2>
      <p>Training must be designed for specific clinical roles, not departments. A certified nurse midwife, a labor and delivery nurse, a perinatologist, and an OB/GYN hospitalist all interact with the same system differently. Generic training produces generic adoption, which in practice means minimal adoption.</p>

      <h2>5. Outcome Measurement Framework</h2>
      <p>Before go-live, every stakeholder must agree on what success looks like, how it will be measured, and at what intervals. Health systems that define this in advance are the ones that generate the data they need to justify continued investment and expansion.</p>

      <h2>Why Most Health Systems Fall Short</h2>
      <p>The honest answer is that clinical readiness is not resourced like a priority because it does not look like a line item. It lives in the space between IT and clinical operations, and both sides tend to assume the other is handling it.</p>
      <p>IT assumes clinical leadership is preparing the teams. Clinical leadership assumes IT is managing the timeline. And the vendor assumes both are ready because the contract is signed.</p>
      <p>This is not a failure of intelligence. It is a structural gap. Most health systems do not have a dedicated clinical readiness function, especially in women's health, where the specialization required to design workflows that reflect ACOG guidelines, address maternal health equity, and integrate into a complex EHR environment is genuinely rare.</p>
      <p>Healthcare in 2026 is shifting from passive EHR adoption to proactive ownership. Health systems that treat EHR modernization as an ongoing discipline rather than a one-time initiative are the ones building the infrastructure for sustainable clinical performance.</p>

      <h2>The Cost of Not Being Ready</h2>
      <p>A failed implementation in women's health is not just an IT problem. It is a patient safety risk, a provider burnout accelerant, and a financial drain. Documentation fatigue in OB/GYN is one of the leading contributors to physician burnout in the specialty. When a new system adds clicks instead of reducing them, it does not just frustrate clinicians. It drives turnover, degrades care quality, and increases liability exposure.</p>
      <blockquote>More than 80% of women report feeling unheard in the healthcare system. When health systems deploy technology that is not clinically ready, they digitize that experience at scale rather than improving it.</blockquote>

      <h2>How The Faulkner Group Closes the Gap</h2>
      <p>The Faulkner Group was built to be the clinical readiness function that most health systems do not have in-house. Led by an Epic-certified consultant with over 13 years of experience in Stork, ClinDoc, and Ambulatory, and co-led by a board-certified OB/GYN with 10 years of clinical practice, our team sits at the intersection of technical precision and real-world clinical judgment.</p>
      <p>We do not hand health systems a framework and leave. We embed alongside your team, map your workflows, identify your gaps, design your training, and stay through go-live and beyond.</p>
      <p>If you are not sure whether your organization is clinically ready, that uncertainty is your answer.</p>
      <p>Start with our <a href="/clinical-readiness-assessment">Clinical Readiness Assessment</a> and find out exactly where you stand before it costs you a deployment.</p>
    `,
  },
  {
    slug: "5-reasons-femtech-pilots-fail",
    title: "The 5 Reasons Femtech Pilots Fail",
    excerpt:
      "Understanding failure at the system level is the first step toward preventing it. Here are the five most common reasons femtech pilots stall before they scale.",
    category: "Clinical Strategy",
    date: "August 8, 2025",
    readTime: "8 min read",
    image: articleFemtechPilots,
    content: `
      <p>Understanding failure at the system level is the first step toward preventing it. Here are the five most common reasons femtech pilots stall before they scale.</p>

      <h2>1. No Clinical Champion With Operational Authority</h2>
      <p>A pilot needs more than a supportive physician. It needs someone with the positional authority to change workflows, update documentation protocols, and hold teams accountable. Without that, even the best technology sits unused after the kickoff call.</p>

      <h2>2. EHR Integration Was Not Scoped Before the Agreement Was Signed</h2>
      <blockquote>Over 58% of healthcare IT professionals say EHR integration challenges are a primary cause of care delays.</blockquote>
      <p>Femtech vendors often sign health system agreements without a confirmed integration pathway into Epic, Oracle Health, or whatever platform the system runs. The result is a disconnected solution that clinicians cannot trust and will not use.</p>

      <h2>3. Clinical Workflows Were Not Mapped in Advance</h2>
      <p>Disruption to clinical workflow is one of the four primary barriers to digital health adoption in practice settings. When a new femtech tool requires clinicians to log into a separate portal, download reports manually, or reenter data, adoption drops immediately. Workflow design has to happen before go-live, not after.</p>

      <h2>4. Staff Were Not Trained for the Specific Clinical Use Case</h2>
      <p>Generic onboarding is not enough. A women's health coordinator using a PCOS management platform has different needs than an OB/GYN using a maternal monitoring tool. Role-specific training tied to real clinical scenarios is what separates a launched product from a used one.</p>

      <h2>5. Success Metrics Were Never Defined</h2>
      <p>If a pilot begins without agreed-upon outcomes, it ends without proof. Health systems renew what they can justify to their CFO. Femtech founders need to enter every pilot with a defined measurement framework tied to clinical outcomes, workflow efficiency, or cost reduction.</p>

      <h2>The Clinical Readiness Gap</h2>
      <p>Clinical readiness is not a buzzword. It is the operational state a health system must reach before a new digital health solution can be deployed safely and effectively.</p>
      <p>It includes workflow mapping, EHR integration planning, staff training, change management, and outcome measurement. When any one of those elements is missing, the pilot is already at risk before the first patient encounter.</p>
      <p>This is the gap The Faulkner Group was built to close. Our work sits at the intersection of clinical expertise and operational strategy. We assess whether a health system is truly ready to adopt, launch, and sustain women's health technology before the agreement is signed. And for femtech founders, we prepare the health system side of the equation so their solution has the environment it needs to perform.</p>
      <blockquote>More than 80% of women report feeling unheard by healthcare professionals. When a femtech tool is deployed into an unprepared system, that experience does not improve. It gets digitized and scaled.</blockquote>

      <h2>What Clinical Readiness Actually Looks Like</h2>
      <p>A clinically ready health system can answer yes to all of the following before a femtech go-live:</p>
      <ul>
        <li>The clinical champion has workflow authority, not just enthusiasm</li>
        <li>The EHR integration pathway is scoped, tested, and approved by IT</li>
        <li>Role-specific training has been delivered to every end user</li>
        <li>A go-live support plan covers the first 30 to 90 days</li>
        <li>Success metrics are documented and aligned with leadership</li>
        <li>Patient communication about the new tool is ready to deploy</li>
      </ul>
      <p>If a health system cannot answer yes to each of those questions, the pilot is not ready to launch. Launching anyway does not accelerate adoption. It accelerates failure.</p>

      <h2>From Pilot to Platform: The Path Forward</h2>
      <p>The femtech sector is maturing fast. By 2026, the era of early-stage pilots and experimental deployments is giving way to a demand for enterprise-grade, reimbursable, scalable platforms. Health system leaders, CMIOs, and femtech founders are all operating under higher scrutiny, tighter budgets, and increasing regulatory complexity.</p>
      <p>The companies that will move from pilot to platform are not necessarily the ones with the most advanced technology. They are the ones that built clinical readiness into their go-to-market strategy from day one.</p>
      <p>That means investing in operational infrastructure, not just product features. It means partnering with advisors who understand both the clinical environment and the implementation process. And it means treating health system readiness as a prerequisite, not an afterthought.</p>

      <h2>Work With The Faulkner Group</h2>
      <p>The Faulkner Group is a boutique advisory firm focused on clinical readiness and operational strategy for women's health technology adoption. We work with health systems to prepare their clinical environment, and with femtech founders to ensure their solution lands in a system that is ready to use it.</p>
      <p>If your pilot has stalled, or you want to make sure your next one does not, start with our Clinical Readiness Assessment. It is the fastest way to identify the gaps before they cost you the contract.</p>
    `,
  },
  {
    slug: "why-physician-adoption-fails",
    title: "Why Physician Adoption Fails and What Founders Can Do About It",
    excerpt:
      "Most health tech companies lose their first health system deal not because of bad technology, but because they never built a physician adoption strategy. Here is what separates winners from the rest.",
    category: "Clinical Strategy",
    date: "July 15, 2025",
    readTime: "6 min read",
    image: articlePhysicianAdoption,
    content: `
      <p>Most health tech companies lose their first health system deal not because of bad technology, but because they never built a physician adoption strategy.</p>
      <p>The assumption is simple: build a great product, show it to hospital leadership, and physicians will adopt it. But that is not how health systems work.</p>
      <h2>The Real Barrier</h2>
      <p>Physician adoption is not a feature problem, it is a workflow problem. Clinicians do not resist technology because they are luddites. They resist technology that adds friction to an already overwhelming day.</p>
      <p>The companies that win understand this. They design their implementation around existing clinical workflows, not against them.</p>
      <h2>Three Things Founders Can Do Today</h2>
      <ol>
        <li><strong>Map the clinical workflow first.</strong> Before you pitch, understand exactly where your product fits in the physician's day. Not the IT team's day, the physician's day.</li>
        <li><strong>Get a clinical champion early.</strong> One physician who believes in your product is worth more than ten IT approvals. Find them, partner with them, and build your case study together.</li>
        <li><strong>Design for the 2-minute test.</strong> If a physician cannot see value within 2 minutes of interaction, adoption will fail. Period.</li>
      </ol>
      <p>At The Faulkner Group, we help founders build physician adoption strategies that actually work, because our team has sat on both sides of the table.</p>
    `,
  },
  {
    slug: "reimbursement-readiness-checklist",
    title: "The Reimbursement Readiness Checklist Every Femtech Founder Needs",
    excerpt:
      "Reimbursement is not a post-launch problem. If you are not building your payer strategy before you go to market, you are already behind.",
    category: "Payer Strategy",
    date: "June 29, 2025",
    readTime: "4 min read",
    image: articleReimbursement,
    content: `
      <p>Reimbursement is not a post-launch problem. If you are not building your payer strategy before you go to market, you are already behind.</p>
      <h2>Why This Matters Now</h2>
      <p>Investors increasingly want to see a clear path to reimbursement before they write a check. Health systems want to know that your product will not become a cost center. And payers want evidence, real evidence, that your solution improves outcomes.</p>
      <h2>The Checklist</h2>
      <ul>
        <li>Do you have a CPT or HCPCS code strategy?</li>
        <li>Have you identified which payers cover your category?</li>
        <li>Do you have clinical evidence that supports reimbursement?</li>
        <li>Have you modeled the total cost of care impact?</li>
        <li>Is your pricing aligned with existing reimbursement rates?</li>
      </ul>
      <p>If you answered "no" to more than two of these, it is time to get serious about reimbursement strategy. Our free Reimbursement Readiness Scorecard can help you benchmark where you stand.</p>
    `,
  },
  {
    slug: "health-system-sales-mistakes",
    title: "5 Health System Sales Mistakes That Kill Deals Before They Start",
    excerpt:
      "Selling to health systems is not like selling to startups. Here are the five most common mistakes we see founders make, and how to avoid them.",
    category: "Health System Strategy",
    date: "June 3, 2025",
    readTime: "5 min read",
    image: articleHealthSystemSales,
    content: `
      <p>Selling to health systems is not like selling to startups or even enterprise SaaS. The sales cycle is longer, the stakeholders are more complex, and the consequences of getting it wrong are severe.</p>
      <h2>Mistake #1: Leading With Features</h2>
      <p>Health system buyers do not care about your feature list. They care about outcomes, cost savings, and risk mitigation. Lead with the business case.</p>
      <h2>Mistake #2: Ignoring the Physician</h2>
      <p>If physicians do not want your product, it does not matter what the CIO thinks. Build physician champions early.</p>
      <h2>Mistake #3: Underestimating Procurement</h2>
      <p>Health system procurement is a 6-18 month process. Plan accordingly and budget for it.</p>
      <h2>Mistake #4: No EHR Integration Strategy</h2>
      <p>If your product does not integrate with Epic, Cerner, or the system's EHR, you are dead on arrival. Have a clear integration roadmap.</p>
      <h2>Mistake #5: Skipping the Pilot</h2>
      <p>Health systems want proof before they scale. Offer a structured pilot with clear success metrics and a path to enterprise deployment.</p>
    `,
  },
];

// ─── HELPERS ──────────────────────────────────────────────────
const allCategories = ["All", ...Array.from(new Set(articles.map((a) => a.category)))];

function extractHeadings(html: string): { id: string; text: string }[] {
  const regex = /<h2[^>]*>(.*?)<\/h2>/gi;
  const headings: { id: string; text: string }[] = [];
  let match;
  while ((match = regex.exec(html)) !== null) {
    const text = match[1].replace(/<[^>]*>/g, "");
    const id = text.toLowerCase().replace(/[^a-z0-9]+/g, "-").replace(/(^-|-$)/g, "");
    headings.push({ id, text });
  }
  return headings;
}

function injectHeadingIds(html: string): string {
  return html.replace(/<h2([^>]*)>(.*?)<\/h2>/gi, (_match, attrs, inner) => {
    const text = inner.replace(/<[^>]*>/g, "");
    const id = text.toLowerCase().replace(/[^a-z0-9]+/g, "-").replace(/(^-|-$)/g, "");
    return `<h2${attrs} id="${id}">${inner}</h2>`;
  });
}

// ─── ARTICLE VIEW ─────────────────────────────────────────────
const ArticleView = ({
  article,
  onBack,
}: {
  article: Article;
  onBack: () => void;
}) => {
  const [activeHeading, setActiveHeading] = useState("");
  const [tocOpen, setTocOpen] = useState(false);
  const contentRef = useRef<HTMLDivElement>(null);
  const headings = extractHeadings(article.content);
  const processedContent = injectHeadingIds(article.content);
  const author = article.author || defaultAuthor;
  const heroImage = article.image || defaultHeroImage;

  // Related articles (exclude current, max 3)
  const related = articles.filter((a) => a.slug !== article.slug).slice(0, 3);

  // Scroll spy for TOC
  useEffect(() => {
    const observer = new IntersectionObserver(
      (entries) => {
        entries.forEach((entry) => {
          if (entry.isIntersecting) {
            setActiveHeading(entry.target.id);
          }
        });
      },
      { rootMargin: "-100px 0px -60% 0px", threshold: 0.1 }
    );

    const els = contentRef.current?.querySelectorAll("h2[id]");
    els?.forEach((el) => observer.observe(el));
    return () => observer.disconnect();
  }, [article.slug]);

  const scrollToHeading = useCallback((id: string) => {
    const el = document.getElementById(id);
    if (el) {
      el.scrollIntoView({ behavior: "smooth", block: "start" });
      setTocOpen(false);
    }
  }, []);

  return (
    <>
      <SEOHead
        title={`${article.title} | The Faulkner Group Insights`}
        description={article.excerpt}
        canonical={`https://thefaulknergroupadvisors.com/insights#${article.slug}`}
      />
      <Header />
      <main className="min-h-screen" style={{ background: "#0f1a2e" }}>
        {/* Back Navigation */}
        <div className="max-w-[1100px] mx-auto px-4 md:px-6 flex" style={{ paddingTop: "max(calc(9rem + 24px), calc(160px + env(safe-area-inset-top, 0px)))", paddingBottom: "24px" }}>
          <div className="flex-1 min-w-0 max-w-[720px] lg:mx-0 mx-auto">
            <button
              onClick={onBack}
              className="inline-flex items-center font-inter text-sm font-medium rounded-lg transition-all duration-300"
              style={{
                gap: "6px",
                padding: "10px 16px",
                color: "#C9A84C",
                background: "rgba(15, 26, 46, 0.4)",
                border: "1px solid #C9A84C",
                backdropFilter: "blur(12px)",
                WebkitBackdropFilter: "blur(12px)",
              }}
              onMouseEnter={(e) => {
                e.currentTarget.style.background = "rgba(25, 40, 65, 0.6)";
                e.currentTarget.style.boxShadow = "0 0 16px rgba(201, 168, 76, 0.25)";
              }}
              onMouseLeave={(e) => {
                e.currentTarget.style.background = "rgba(15, 26, 46, 0.4)";
                e.currentTarget.style.boxShadow = "none";
              }}
            >
              ← Back to Insights
            </button>
          </div>
          <div className="hidden lg:block w-[240px] flex-shrink-0" />
        </div>

        {/* Hero Image */}
        <div className="relative w-full h-[260px] md:h-[380px]">
          <img
            src={heroImage}
            alt={article.title}
            className="w-full h-full object-cover"
          />
          <div
            className="absolute inset-0"
            style={{
              background:
                "linear-gradient(to bottom, rgba(15,26,46,0.3) 0%, rgba(15,26,46,0.85) 70%, rgba(15,26,46,1) 100%)",
            }}
          />
          <div className="absolute bottom-0 left-0 right-0 px-4 md:px-6 pb-6 md:pb-10">
            <div className="max-w-[720px] mx-auto">
              <div className="flex flex-wrap items-center gap-2 md:gap-3 mb-3 md:mb-4">
                <span className="bg-[#C9A84C]/20 text-[#C9A84C] text-xs font-semibold px-3 py-1 rounded-full font-inter">
                  {article.category}
                </span>
                <span className="text-white/50 text-xs md:text-sm font-inter flex items-center gap-1">
                  <Calendar size={12} /> {article.date}
                </span>
                <span className="text-white/50 text-xs md:text-sm font-inter flex items-center gap-1">
                  <Clock size={12} /> {article.readTime}
                </span>
              </div>
              <h1
                className="text-2xl md:text-[2.75rem] font-playfair text-white leading-tight text-left"
                style={{
                  textShadow:
                    "0 2px 12px rgba(0,0,0,0.8), 0 4px 24px rgba(0,0,0,0.6)",
                }}
              >
                {article.title}
              </h1>
            </div>
          </div>
        </div>

        {/* Mobile TOC */}
        {headings.length > 0 && (
          <div className="lg:hidden max-w-[720px] mx-auto px-4 md:px-6 mt-6 md:mt-8">
            <button
              onClick={() => setTocOpen(!tocOpen)}
              className="w-full flex items-center justify-between px-4 py-3 rounded-lg font-inter text-sm font-medium text-white/80"
              style={{ background: "rgba(255,255,255,0.06)", border: "1px solid rgba(255,255,255,0.1)" }}
            >
              <span>Table of Contents</span>
              {tocOpen ? <ChevronUp size={16} /> : <ChevronDown size={16} />}
            </button>
            {tocOpen && (
              <nav className="mt-2 rounded-lg p-3 md:p-4 space-y-1 md:space-y-2 max-h-[50vh] overflow-y-auto" style={{ background: "rgba(255,255,255,0.04)" }}>
                {headings.map((h) => (
                  <button
                    key={h.id}
                    onClick={() => scrollToHeading(h.id)}
                    className={`block w-full text-left text-sm font-inter py-1.5 px-3 rounded transition-colors duration-200 ${
                      activeHeading === h.id
                        ? "text-[#C9A84C] bg-[#C9A84C]/10"
                        : "text-white/50 hover:text-white/80"
                    }`}
                  >
                    {h.text}
                  </button>
                ))}
              </nav>
            )}
          </div>
        )}

        {/* Content + Desktop TOC */}
        <div className="max-w-[1100px] mx-auto px-4 md:px-6 pt-8 md:pt-10 pb-12 md:pb-16 flex gap-12">
          {/* Article Content */}
          <div className="flex-1 min-w-0 max-w-[720px] mx-auto lg:mx-0">
            <div
              ref={contentRef}
              className="article-content font-inter"
              style={{ fontSize: "17px", lineHeight: "1.8", color: "#D1D5DB" }}
              dangerouslySetInnerHTML={{ __html: processedContent }}
            />

            {/* Gold divider */}
            <div className="my-8 md:my-12 h-px" style={{ background: "linear-gradient(to right, transparent, #C9A84C40, transparent)" }} />

            {/* Author Bio */}
            <div
              className="rounded-xl p-5 md:p-8 flex flex-col sm:flex-row items-center sm:items-start gap-4 md:gap-6"
              style={{ background: "rgba(255,255,255,0.04)", border: "1px solid rgba(255,255,255,0.08)" }}
            >
              <img
                src={author.headshot}
                alt={author.name}
                className="w-16 h-16 md:w-20 md:h-20 rounded-full object-cover flex-shrink-0"
                style={{ border: "2px solid #C9A84C" }}
              />
              <div className="text-center sm:text-left">
                <h3 className="text-white font-playfair text-base md:text-lg font-bold mb-1 text-center sm:text-left">
                  {author.name}
                </h3>
                <p className="text-[#C9A84C] font-inter text-xs md:text-sm mb-2 md:mb-3">
                  {author.title}
                </p>
                <p className="text-white/60 font-inter text-xs md:text-sm leading-relaxed">
                  {author.bio}
                </p>
              </div>
            </div>

            {/* Gold divider */}
            <div className="my-8 md:my-12 h-px" style={{ background: "linear-gradient(to right, transparent, #C9A84C40, transparent)" }} />

            {/* Continue Reading */}
            {related.length > 0 && (
              <section>
                <h2 className="text-xl md:text-2xl font-playfair text-white mb-6 md:mb-8 text-left">
                  Continue Reading
                </h2>
                <div className="grid gap-4 md:gap-6 grid-cols-1 sm:grid-cols-2 lg:grid-cols-3">
                  {related.map((r) => (
                    <button
                      key={r.slug}
                      onClick={() => {
                        onBack();
                        setTimeout(() => {
                          window.scrollTo(0, 0);
                        }, 0);
                      }}
                      className="group text-left rounded-xl p-4 md:p-5 transition-all duration-300 hover:shadow-[0_0_20px_rgba(201,168,76,0.15)]"
                      style={{
                        background: "rgba(255,255,255,0.04)",
                        border: "1px solid rgba(201,168,76,0.18)",
                        boxShadow: "0 0 12px rgba(201,168,76,0.06), inset 0 1px 0 rgba(201,168,76,0.08)",
                      }}
                    >
                      <span className="inline-block bg-[#C9A84C]/15 text-[#C9A84C] text-xs font-semibold px-2.5 py-0.5 rounded-full font-inter mb-3">
                        {r.category}
                      </span>
                      <h3 className="text-white font-playfair text-sm md:text-base mb-2 group-hover:text-[#C9A84C] transition-colors text-left">
                        {r.title}
                      </h3>
                      <span className="text-white/40 text-xs font-inter">
                        {r.date}
                      </span>
                    </button>
                  ))}
                </div>
              </section>
            )}
          </div>

          {/* Desktop TOC Sidebar */}
          {headings.length > 0 && (
            <aside className="hidden lg:block w-[240px] flex-shrink-0 sticky top-36 self-start">
              <p className="text-white/40 font-inter text-xs uppercase tracking-widest mb-4">
                On this page
              </p>
              <nav className="space-y-1.5">
                {headings.map((h) => (
                  <button
                    key={h.id}
                    onClick={() => scrollToHeading(h.id)}
                    className={`block w-full text-left text-[13px] font-inter py-1.5 pl-3 border-l-2 transition-all duration-200 ${
                      activeHeading === h.id
                        ? "border-[#C9A84C] text-[#C9A84C]"
                        : "border-transparent text-white/40 hover:text-white/70 hover:border-white/20"
                    }`}
                  >
                    {h.text}
                  </button>
                ))}
              </nav>
            </aside>
          )}
        </div>

        {/* Full-width CTA Banner */}
        <section
          className="py-12 md:py-20 px-4 md:px-6"
          style={{
            background:
              "linear-gradient(135deg, #0a1628 0%, #142238 50%, #0a1628 100%)",
            borderTop: "1px solid rgba(201,168,76,0.15)",
          }}
        >
          <div className="max-w-3xl mx-auto text-center">
            <h2 className="text-2xl md:text-4xl font-playfair text-white mb-3 md:mb-4">
              Ready to Close the Clinical Readiness Gap?
            </h2>
            <p className="text-white/60 font-inter text-base md:text-lg mb-6 md:mb-8 max-w-xl mx-auto">
              Whether your pilot has stalled or you are preparing your first health system partnership, our team can help you build the clinical foundation for success.
            </p>
            <a
              href="/clinical-clarity-session"
              className="inline-flex items-center gap-2 px-6 md:px-8 py-3.5 md:py-4 rounded-lg font-inter font-semibold text-sm md:text-base transition-all duration-300 hover:scale-[1.03]"
              style={{
                background: "#C9A84C",
                color: "#0f1a2e",
                boxShadow: "0 0 30px rgba(201,168,76,0.25)",
              }}
            >
              Schedule a Clinical Clarity Session
              <ArrowRight size={18} />
            </a>
          </div>
        </section>
      </main>
      <BottomVideo />
      <StickyCTA />
    </>
  );
};

// ─── LISTING VIEW ─────────────────────────────────────────────
const Insights = () => {
  const [selectedCategory, setSelectedCategory] = useState("All");
  const [selectedArticle, setSelectedArticle] = useState<Article | null>(null);

  const filtered =
    selectedCategory === "All"
      ? articles
      : articles.filter((a) => a.category === selectedCategory);

  if (selectedArticle) {
    return (
      <ArticleView
        article={selectedArticle}
        onBack={() => setSelectedArticle(null)}
      />
    );
  }

  return (
    <>
      <SEOHead
        title="Insights | The Faulkner Group — Clinical Strategy Articles"
        description="Expert insights on clinical strategy, physician adoption, reimbursement, and health system partnerships from The Faulkner Group."
        canonical="https://thefaulknergroupadvisors.com/insights"
      />
      <Header />
      <main className="min-h-screen" style={{ background: "#0f1a2e" }}>
        {/* Hero */}
        <section className="relative w-full overflow-hidden pt-[calc(140px+env(safe-area-inset-top,0px))] pb-[32px] md:pt-[180px] md:pb-[60px]">
          <img
            src="/hero-boardroom.jpg"
            alt="Healthcare strategy and clinical insights"
            className="absolute inset-0 w-full h-full object-cover"
            fetchPriority="high"
            decoding="async"
          />
          <div className="absolute inset-0" style={{ backgroundColor: 'rgba(10, 22, 40, 0.6)' }} />

          <div className="relative z-10 flex items-center justify-center px-6 text-center">
            <div className="max-w-[820px]">
              <p
                className="mb-4 font-inter font-medium uppercase"
                style={{
                  fontSize: '13px',
                  letterSpacing: '0.2em',
                  color: 'hsl(45, 62%, 56%)'
                }}
              >
                Expert Perspectives
              </p>

              <h1
                className="mb-4 md:mb-6 font-display font-bold text-white"
                style={{ fontSize: 'clamp(26px, 3.8vw, 52px)', lineHeight: 1.1 }}
              >
                <span className="block">Insights</span>
              </h1>

              <p
                className="mb-6 md:mb-10 font-inter px-2 max-w-2xl mx-auto"
                style={{
                  fontSize: 'clamp(14px, 1.6vw, 20px)',
                  color: 'rgba(255,255,255,0.85)',
                  textShadow: '0 2px 8px rgba(0,0,0,0.5)',
                  textWrap: 'balance' as any,
                  lineHeight: 1.6,
                }}
              >
                Expert perspectives on clinical strategy, health system partnerships, and building health tech that scales.
              </p>
            </div>
          </div>
        </section>

        {/* Category Filter */}
        <div className="max-w-5xl mx-auto px-4 md:px-6 pt-6 md:pt-10 mb-6 md:mb-12 flex flex-wrap justify-center gap-2 md:gap-3">
          {allCategories.map((cat) => (
            <button
              key={cat}
              onClick={() => setSelectedCategory(cat)}
              className={`px-3 md:px-4 py-1.5 md:py-2 rounded-full text-xs md:text-sm font-inter font-medium transition-all duration-300 ${
                selectedCategory === cat
                  ? "text-[#0f1a2e]"
                  : "text-white/70 hover:text-white"
              }`}
              style={{
                background:
                  selectedCategory === cat
                    ? "#C9A84C"
                    : "rgba(255,255,255,0.08)",
              }}
            >
              {cat}
            </button>
          ))}
        </div>

        {/* Articles Grid */}
        <div className="max-w-5xl mx-auto px-4 md:px-6 pb-16 md:pb-24 grid gap-5 md:gap-8 grid-cols-1 md:grid-cols-2 lg:grid-cols-3">
          {filtered.map((article) => (
            <button
              key={article.slug}
              onClick={() => {
                setSelectedArticle(article);
                window.scrollTo(0, 0);
              }}
              className="group text-left rounded-xl overflow-hidden transition-all duration-300 hover:shadow-[0_0_20px_rgba(201,168,76,0.15)]"
              style={{
                background: "rgba(255,255,255,0.04)",
                border: "1px solid rgba(201,168,76,0.18)",
                boxShadow: "0 0 12px rgba(201,168,76,0.06), inset 0 1px 0 rgba(201,168,76,0.08)",
              }}
            >
              <div className="h-40 overflow-hidden relative">
                <img
                  src={article.image || defaultHeroImage}
                  alt={article.title}
                  className="w-full h-full object-cover group-hover:scale-105 transition-transform duration-500"
                  loading="lazy"
                />
                <div className="absolute inset-0" style={{ background: "linear-gradient(to bottom, transparent 40%, rgba(0,0,0,0.2) 100%)" }} />
              </div>
              <div className="p-4 md:p-6">
                <span className="inline-block bg-[#C9A84C]/15 text-[#C9A84C] text-xs font-semibold px-3 py-1 rounded-full font-inter mb-3">
                  {article.category}
                </span>
                <h2 className="text-lg font-playfair text-white mb-3 group-hover:text-[#C9A84C] transition-colors duration-300 text-left leading-snug">
                  {article.title}
                </h2>
                <p className="text-white/50 font-inter text-sm mb-4 line-clamp-2">
                  {article.excerpt}
                </p>
                <div className="flex items-center justify-between">
                  <span className="text-white/30 text-xs font-inter flex items-center gap-1">
                    <Calendar size={12} /> {article.date}
                  </span>
                  <span className="text-[#C9A84C] text-sm font-inter flex items-center gap-1 opacity-0 group-hover:opacity-100 transition-opacity duration-300">
                    Read <ArrowRight size={14} />
                  </span>
                </div>
              </div>
            </button>
          ))}
        </div>

        {filtered.length === 0 && (
          <p className="text-center text-white/50 font-inter pb-24">
            No articles in this category yet. Check back soon.
          </p>
        )}
      </main>
      <BottomVideo />
      <StickyCTA />
    </>
  );
};

export default Insights;
